The DOI matches its Crossref record.
Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF‐κB activation
Open accessAbstract
Cyclosporine A is an immunosuppressive agent that is used clinically in the prevention of transplant rejection and development of graft‐versus‐host disease. Recently, cyclosporine A has been shown to possess anti‐inflammatory properties and is capable of inhibiting lipopolysaccharide‐induced NF‐κB activation. Ubiquitin‐mediated proteasomal proteolysis plays a critical role in signal‐induced NF‐κB activation since it regulates both IκB degradation and p105 processing, it is also involved in the production of peptides for the assembly of MHC class I molecules. We report here that cylcosporine A acts as an uncompetitive inhibitor of the chymotrypsin‐like activity of the 20S proteasome in vitro and that it suppresses lipopolysaccharide‐induced IκB degradation and p105 processing in vivo demonstrating that inhibition of proteasome proteolysis is the mechanism by which cyclosporine A prevents NF‐κB activation. A structurally unrelated immunosuppressant, rapamycin, did not inhibit the 20S proteasome in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,585
Inhibiting NF-κB activation by small molecules as a therapeutic strategy
Gupta, S. C., Sundaram, C., Reuter, S., & Aggarwal, B. B. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.05.004 · Cited by 762
NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis
Roman-Blas, J. A., & Jimenez, S. A. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.04.008 · Cited by 688
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
Park, M., & Hong, J. (2016) · Cells · doi:10.3390/cells5020015 · Cited by 627
Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic Target
Lee, J., & Burckart, G. J. (1998) · The Journal of Clinical Pharmacology · doi:10.1177/009127009803801101 · Cited by 365
Metadata
- Authors
- Meyer, S., Kohler, N. G., & Joly, A.
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 1997-08-18
- Volume
- 413
- Issue
- 2
- Pages
- 354-358
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2155596800
- Cited by
- 161
- References
- 0
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF‐κB activation. https://app.cochat.ai/papers/10.1016/s0014-5793(97)00930-7
- The paper
- Meyer, S., Kohler, N. G., & Joly, A. (1997). Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF‐κB activation. FEBS Letters. https://doi.org/10.1016/s0014-5793(97)00930-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.